Filing Details

Accession Number:
0000950170-24-047687
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-24 17:00:22
Reporting Period:
2024-04-22
Accepted Time:
2024-04-24 17:00:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1703647 Korro Bio Inc. KRRO Pharmaceutical Preparations (2834) 472324450
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746342 Carmen Chang 2855 Sand Hill Road
Menlo Park CA 94025
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-22 17,857 $56.00 1,090,793 No 4 P Indirect See Note 2
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Note 2
Footnotes
  1. Acquired from the Issuer on April 22, 2024 pursuant to a Subscription Agreement dated April 17, 2024.
  2. The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.